Effect of Mobile Communication With a Cellular Phone With a Glucometer on Glucose Control in Type 2 Diabetic Patients
1 other identifier
interventional
80
1 country
1
Brief Summary
Previously we demonstrated the beneficial effects of an Internet-based glucose-monitoring system (IBGMS) in people with type 2 diabetes mellitus. The "Diabetes Phone", a cellular phone with a glucometer integrated in the battery pack, was launched in Korea in 2003. Here we test the short-term effectiveness of the diabetes phone for glucose control and compare it with that of IBGMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Dec 2004
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 13, 2006
CompletedFirst Posted
Study publicly available on registry
December 15, 2006
CompletedDecember 15, 2006
December 1, 2006
December 13, 2006
December 14, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
Secondary Outcomes (1)
Compliance
Interventions
Eligibility Criteria
You may qualify if:
- Patients with type 2 diabetes mellitus who were able to operate the Internet and to communicate through a mobile phone using the short message service
You may not qualify if:
- Significant disease conditions such as symptomatic heart failure, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels more than twice the normal level, renal disease and creatinine level greater than 1.5 mg/dL.
- Patients were also excluded if they participated in other programs that provided information or education about diabetes management from any Internet websites or by any cellular phones other than ours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kangnam St. Mary's Hospital, The Catholic University of Korea
Seoul, 137-040, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jae-Hyoung Cho, Instructor
Kangnam St. Mary's Hospital, The Catholic University of Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 13, 2006
First Posted
December 15, 2006
Study Start
December 1, 2004
Study Completion
April 1, 2005
Last Updated
December 15, 2006
Record last verified: 2006-12